Skip to main content
Fig. 7 | Journal of Nanobiotechnology

Fig. 7

From: Improving the ameliorative effects of berberine and curcumin combination via dextran-coated bilosomes on non-alcohol fatty liver disease in mice

Fig. 7

Evaluation of amelioration effects on NAFLD in mice after treatments. A Schematic diagram of the animal grouping and treatment. B Variation on body weight of mice during the treatments. C Detection of fat weight and BFR and D FSG at the end of experiments. E The H&E staining (black arrow indicates inflammatory foci). F Oil-Red-O staining with hematoxylin counterstain. Each bar represents the mean  ±  SD (n  =  6). ***p  <  0.001 Model vs ND; ###p  <  0.001 vs Model; §§p  <  0.01 and §§§p  <  0.001 vs DEAE-DEX@LSDBC

Back to article page